Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Proglumide with Chemotherapy on the Pancreatic Tumor Microenvironment: Phase 1 PROGEM Trial.

Pharmaceutics·2026
Same author

Liver Transplantation for Diffuse Infantile Hepatic Hemangioma and Acute Liver Failure: A Case Report.

Pediatric transplantation·2026
Same author

Dual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially inhibits estrogen receptor positive breast cancer cell growth.

PloS one·2024
Same author

LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency.

Cancer research communications·2024
Same author

Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 Inhibition.

Molecular cancer therapeutics·2023
Same author

Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate Cancers.

Clinical cancer research : an official journal of the American Association for Cancer Research·2022

Related Experiment Video

Updated: Aug 5, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K

Novel Paired Normal Prostate and Prostate Cancer Model Cell Systems Derived from African American Patients.

Mira Jung1, Keith Kowalczyk2,3, Ryan Hankins2,3

  • 1Department of Radiation Medicine, Georgetown University School of Medicine, Washington, District of Columbia.

Cancer Research Communications
|March 27, 2023
PubMed
Summary
This summary is machine-generated.

New prostate cancer models derived from African American (AA) patients offer insights into health disparities. These models enable preclinical studies and drug screening for improved understanding and treatment of prostate cancer in AA men.

More Related Videos

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells
08:03

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells

Published on: October 20, 2015

14.2K
A Rapid Filter Insert-based 3D Culture System for Primary Prostate Cell Differentiation
09:23

A Rapid Filter Insert-based 3D Culture System for Primary Prostate Cell Differentiation

Published on: February 13, 2017

8.6K

Related Experiment Videos

Last Updated: Aug 5, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K
Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells
08:03

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells

Published on: October 20, 2015

14.2K
A Rapid Filter Insert-based 3D Culture System for Primary Prostate Cell Differentiation
09:23

A Rapid Filter Insert-based 3D Culture System for Primary Prostate Cell Differentiation

Published on: February 13, 2017

8.6K

Area of Science:

  • Oncology
  • Genetics
  • Cell Biology

Background:

  • Prostate cancer disproportionately affects African American (AA) men, with higher incidence and mortality rates.
  • Existing preclinical models inadequately represent the molecular complexity of prostate cancer in AA populations, hindering research into health disparities.
  • There is a critical need for advanced in vitro and in vivo models to investigate the underlying mechanisms of prostate cancer in AA men.

Purpose of the Study:

  • To establish and characterize novel preclinical cell culture models from prostate tumors of African American patients.
  • To investigate the molecular differences between tumor-derived and normal prostate epithelial cells from the same donors.
  • To assess the utility of these models for preclinical drug screening and understanding health disparities in prostate cancer.

Main Methods:

  • Paired tumor and normal epithelial cell cultures were established from radical prostatectomy specimens of AA patients.
  • Cells were cultivated using conditional reprogramming to extend growth and maintain characteristics.
  • Immunocytochemistry was used to analyze marker expression (CK8, CK5, p63, TOPK, c-MYC, N-MYC).
  • Drug sensitivity assays were performed using bicalutamide, olaparib, and niraparib to assess cell viability.

Main Results:

  • Ten paired tumor-derived and normal epithelial cell lines were successfully established, exhibiting intermediate risk and predominantly diploid characteristics.
  • Tumor cells showed significantly increased expression of TOPK, c-MYC, and N-MYC compared to normal cells.
  • Tumor-derived cells exhibited decreased viability when exposed to bicalutamide, olaparib, and niraparib compared to normal prostate-derived cells.

Conclusions:

  • Paired prostate epithelial cell cultures from AA patients provide a valuable in vitro model system that recapitulates clinical complexity.
  • These models are suitable for studying molecular mechanisms driving prostate cancer health disparities in AA men.
  • The models demonstrate potential for screening therapeutic drugs, including antiandrogens and PARP inhibitors, for efficacy in this population.